Literature DB >> 4384494

Bacterial factors chemotactic for polymorphonuclear leukocytes.

P A Ward, I H Lepow, L J Newman.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4384494      PMCID： PMC2013377     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  10 in total

1.  SUBSTANCES PROMOTING LEUKOCYTE EMIGRATION.

Authors:  J V HURLEY
Journal:  Ann N Y Acad Sci       Date:  1964-08-27       Impact factor: 5.691

2.  Mobilization of defensive cells in inflammatory tissue.

Authors:  H HARRIS
Journal:  Bacteriol Rev       Date:  1960-03

3.  Role of chemotaxis in inflammation.

Authors:  H HARRIS
Journal:  Physiol Rev       Date:  1954-07       Impact factor: 37.312

4.  Further studies on the chemotactic factor of complement and its formation in vivo.

Authors:  P A Ward; C G Cochrane; H J Muller-Eberhard
Journal:  Immunology       Date:  1966-08       Impact factor: 7.397

5.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

6.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

7.  Partial biochemical characterization of the activated esterase required in the complement-dependent chemotaxis of rabbit polymorphonuclear leukocytes.

Authors:  E L Becker; P A Ward
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

8.  Mechanisms of the inhibition of chemotaxis by phosphonate esters.

Authors:  P A Ward; E L Becker
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

9.  A plasmin-split fragment of C'3 as a new chemotactic factor.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

10.  THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.

Authors:  P A WARD; C G COCHRANE; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307
  10 in total
  96 in total

1.  Inflammatory mediators in culture filtrates of Escherichia coli.

Authors:  T Yoshida; S Cohen; P E Bigazzi; T Kurasuji; A Amsden
Journal:  Am J Pathol       Date:  1975-11       Impact factor: 4.307

2.  Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries.

Authors:  G D Warden; A D Mason; B A Pruitt
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

3.  In vitro and in vivo production of chemotactic inhibitors by tumor cells.

Authors:  M C Cohen; J P Brozna; P A Ward
Journal:  Am J Pathol       Date:  1979-03       Impact factor: 4.307

4.  [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

Authors:  D Niethammer; A Wildfeuer; E Kleihauer; O Haferkamp
Journal:  Klin Wochenschr       Date:  1975-08-15

Review 5.  Role of G protein-coupled receptors in inflammation.

Authors:  Lei Sun; Richard D Ye
Journal:  Acta Pharmacol Sin       Date:  2012-02-27       Impact factor: 6.150

6.  Haematological effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in man.

Authors:  M J Peters; A B Breslin; A S Kemp; J Chu; N Berend
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

7.  A unique complement derived chemotactic factor for tumor cells.

Authors:  A G Romualdez; P A Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

8.  Role for endotoxin in the leukocyte infiltration accompanying Escherichia coli inflammation.

Authors:  A C Issekutz; S Bhimji
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

9.  Defective granulocyte chemotaxis in the Chediak-Higashi syndrome.

Authors:  R A Clark; H R Kimball
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

10.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.